Literature DB >> 32345920

Returning to work after head and neck cancer.

Abi Miller1,2.   

Abstract

PURPOSE OF REVIEW: There is a lack of evidence worldwide on return to work (RTW) in head and neck cancer (HNC), possibly because traditionally those suffering with it were typically at retirement age and survival rates were low. However, in the last 30 years, HNC survival rates have increased, resulting in more people living with the after-effects of treatment for longer, and many are of working-age. The HNC population is also changing because of a 20% increased incidence of oral and pharyngeal HNCs especially in the under 65 years of age, likely accounted for by the surge in human papilloma virus positive related HNCs. RECENT
FINDINGS: The literature suggests that people who have had treatment for HNC return to work less than other cancers. The knowledge base on RTW after HNC is emergent and conclusions are currently difficult to draw. The process of returning and remaining in work is complex, affected by multiple factors and interactions. There is little evidence about work-related experiences from the perspectives of HNC survivors.
SUMMARY: There is an urgent need for more in-depth exploration of the needs and concerns of HNC survivors returning to work after treatment, with the ultimate aim of work-related intervention development.

Entities:  

Mesh:

Year:  2020        PMID: 32345920     DOI: 10.1097/MOO.0000000000000628

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  2 in total

1.  Psychometric properties of self-reported financial toxicity measures in cancer survivors: a systematic review.

Authors:  Zheng Zhu; Weijie Xing; Huan Wen; Yanling Sun; Winnie K W So; Lucylynn Lizarondo; Jian Peng; Yan Hu
Journal:  BMJ Open       Date:  2022-06-24       Impact factor: 3.006

2.  Effect of Radiotherapy on Functional and Health-Related Quality of Life Outcomes after Jaw Reconstruction.

Authors:  Rebecca L Venchiarutti; Masako Dunn; Emma Charters; Kai Cheng; Catriona Froggatt; Payal Mukherjee; Christine Wallace; Dale Howes; David Leinkram; Jasvir Singh; Kevin Nguyen; Tsu-Hui Hubert Low; Sydney Ch'ng; James Wykes; Raymond Wu; Jonathan R Clark
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.